Circulation, Vol 86, 1217-1222, Copyright © 1992 by American Heart Association
W Jung, M Manz, R Moosdorf and B Luderitz
BACKGROUND. Shock delivery of an implantable defibrillator may cause a
change in the amplitude of endocardial electrograms and impair the
detection of ventricular fibrillation. Thus, the effects of shock
discharges on the amplitude of endocardial electrograms were evaluated in
five patients undergoing implantation of a cardioverter- defibrillator in
combination with a new nonthoracotomy lead system. METHODS AND RESULTS. At
implant, bipolar endocardial electrograms were recorded before each shock
application, during ventricular fibrillation, during redetection of
ventricular fibrillation in case the applied shock was ineffective, and at
intervals of 5, 10, 20, 30, 60, and 120 seconds after each shock delivery.
The amplitude of the endocardial electrograms decreased from 10.5 +/- 3.8
mV during sinus rhythm to 6.3 +/- 1.9 mV during initial ventricular
fibrillation and declined to 2.2 +/- 1.3 mV during redetection of
ventricular fibrillation. After successful termination, the following
bipolar electrograms could be obtained at the predetermined intervals: 1.9
+/- 1.2 mV, 3.1 +/- 1.8 mV, 4.5 +/- 1.9 mV, 6.5 +/- 2.9 mV, 9.5 +/- 3.3 mV,
and 10.4 +/- 3.8 mV. At predischarge testing, failure of redetection of
ventricular fibrillation could be documented in two patients, requiring
rescue external defibrillation in both cases to restore sinus rhythm.
CONCLUSIONS. These findings demonstrate that the implantable
cardioverter-defibrillator did not ensure reliable redetection of
ventricular fibrillation in patients using the implanted nonthoracotomy
lead system. Thus, the potential risk of sudden cardiac death may persist
in these patients despite defibrillator therapy.
ARTICLES
Failure of an implantable cardioverter-defibrillator to redetect ventricular fibrillation in patients with a nonthoracotomy lead system
Department of Cardiology, University of Bonn, Germany.
This article has been cited by other articles:
![]() |
C. D. Swerdlow Implantation of Cardioverter Defibrillators Without Induction of Ventricular Fibrillation Circulation, May 1, 2001; 103(17): 2159 - 2164. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Pires, M. H. Lehmann, R. T. Steinman, J. J. Baga, C. D. Schuger, and Participating Investigators Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses J. Am. Coll. Cardiol., January 1, 1999; 33(1): 24 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Epstein, G. N. Kay, V. J. Plumb, S. M. Dailey, and P. G. Anderson Gross and Microscopic Pathological Changes Associated With Nonthoracotomy Implantable Defibrillator Leads Circulation, October 13, 1998; 98(15): 1517 - 1524. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Natale, J. Sra, K. Axtell, M. Akhtar, K. Newby, V. Kent, M. J. Geiger, M. J. Brandon, M. M. Kearney, and A. Pacifico Undetected Ventricular Fibrillation in Transvenous Implantable Cardioverter-Defibrillators : Prospective Comparison of Different Lead System–Device Combinations Circulation, January 1, 1996; 93(1): 91 - 98. [Abstract] [Full Text] |
||||
![]() |
E. U. Alt, P. C. Fotuhi, R. L. Callihan, E. Mestre, W. M. Smith, and R. E. Ideker Endocardial Carbon-Braid Electrodes : A New Concept for Lower Defibrillation Thresholds Circulation, September 15, 1995; 92(6): 1627 - 1633. [Abstract] [Full Text] |
||||
![]() |
A. S. Manolis Transvenous Endocardial Cardioverter Defibrillator Systems: Is the Future Here? Arch Intern Med, March 28, 1994; 154(6): 617 - 622. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |